Literature DB >> 8746297

Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious.

J A Baron1.   

Abstract

Cigarette smoking is an established risk factor for cancer and cardiovascular disease, and is the leading cause of avoidable disease in most industrialized countries. Less well-known are possible beneficial effects, which are briefly considered in this survey. Preliminary data suggest that there may be inverse associations of smoking with uterine fibroids and endometriosis, and protective effects on hypertensive disorders and vomiting of pregnancy are likely. Smoking has consistently been found to be inversely related to the risk of endometrial cancer, but cancers of the breast and colon seem unrelated to smoking. Inverse associations with venous thrombosis and fatality after myocardial infarction are probably not causal, but indications of benefits with regard to recurrent aphthous ulcers, ulcerative colitis, and control of body weight may well reflect a genuine benefit. Evidence is growing that cigarette smoking and nicotine may prevent or ameliorate Parkinson's disease, and could do so in Alzheimer's dementia. A variety of mechanisms for potentially beneficial effects of smoking have been proposed, but three predominate: the 'anti-estrogenic effect' of smoking; alterations in prostaglandin production; and stimulation of nicotinic cholinergic receptors in the central nervous system. Even established inverse associations cannot be used as a rationale for cigarette smoking. These data can be used, however, to clarify mechanisms of disease, and point to productive treatment or preventive options with more narrowly-acting interventions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8746297     DOI: 10.1093/oxfordjournals.bmb.a011533

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  38 in total

1.  Smoking and dementia in male British doctors: prospective study.

Authors:  R Doll; R Peto; J Boreham; I Sutherland
Journal:  BMJ       Date:  2000-04-22

2.  Smoking and the brain.

Authors:  C Brayne
Journal:  BMJ       Date:  2000-04-22

3.  Region-specific transcriptional response to chronic nicotine in rat brain.

Authors:  J K Kane; T Barrett; M P Vawter; R Chang; J Z Ma; D M Donovan; B Sharp; K G Becker; M D Li
Journal:  Brain Res       Date:  2001-08-03       Impact factor: 3.252

Review 4.  Microarray technology and its application on nicotine research.

Authors:  Ming D Li; Ozien Konu; Justin K Kane; Kevin G Becker
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

5.  Smoking and inflammatory bowel diseases: what in smoking alters the course?

Authors:  A M El-Tawil
Journal:  Int J Colorectal Dis       Date:  2010-03-24       Impact factor: 2.571

6.  Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.

Authors:  Susan E Olivo-Marston; Leah E Mechanic; Steen Mollerup; Elise D Bowman; Alan T Remaley; Michele R Forman; Vidar Skaug; Yun-Ling Zheng; Aage Haugen; Curtis C Harris
Journal:  Carcinogenesis       Date:  2010-08-20       Impact factor: 4.944

Review 7.  The Role of Stem Cells in the Etiology and Pathophysiology of Endometriosis.

Authors:  Demetra Hufnagel; Fei Li; Emine Cosar; Graciela Krikun; Hugh S Taylor
Journal:  Semin Reprod Med       Date:  2015-09-16       Impact factor: 1.303

8.  [Effects of nicotine with special consideration given to tumorigenesis in the head and neck region].

Authors:  M P Semmler; O Driemel; R Staudenmaier; K Froelich; N H Kleinsasser
Journal:  Mund Kiefer Gesichtschir       Date:  2006-11

9.  Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report.

Authors:  Xavier Tekpli; Vidar Skaug; Rita Bæra; David H Phillips; Aage Haugen; Steen Mollerup
Journal:  Cell Oncol (Dordr)       Date:  2016-08-29       Impact factor: 6.730

Review 10.  Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.

Authors:  J E Henningfield; N L Benowitz; J Slade; T P Houston; R M Davis; S D Deitchman
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.